Literature DB >> 10918389

Mapping of the chromosome 19 q-arm glioma tumor suppressor gene using fluorescence in situ hybridization and novel microsatellite markers.

J S Smith1, I Tachibana, H K Lee, J Qian, U Pohl, H W Mohrenweiser, T J Borell, S M Hosek, C L Soderberg, A von Deimling, A Perry, B W Scheithauer, D N Louis, R B Jenkins.   

Abstract

Allelic loss of chromosome arm 19q is a frequent event in human diffuse glioma, suggesting the presence of a tumor suppressor gene. Previous loss of heterozygosity (LOH) analyses have mapped this gene to a 1.4-megabase interval, between the genetic markers D19S412 and STD. Further narrowing of this interval has been limited by the resolution of mapped polymorphic markers. In the present study, we have used genomic clones mapped to 19q as fluorescence in situ hybridization (FISH) probes to map the breakpoints of 13 gliomas with 19q13.3 deletion boundaries. In addition, we have developed three new polymorphic microsatellite markers (D19S1180, D19S1181, and D19S1182) that map between D19S412 and STD and have used these new markers to identify two gliomas with small deletions between the D19S412 and STD markers. Collectively, these data suggest that the region of common deletion may be as narrow as 150 kb and should facilitate future efforts to identify the glioma 19q tumor suppressor gene. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2000        PMID: 10918389     DOI: 10.1002/1098-2264(2000)9999:9999<::aid-gcc1007>3.3.co;2-9

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  21 in total

1.  Oligodendroglial-specific transcriptional factor SOX10 is ubiquitously expressed in human gliomas.

Authors:  Sergei I Bannykh; C Claus Stolt; Jung Kim; Arie Perry; Michael Wegner
Journal:  J Neurooncol       Date:  2006-01       Impact factor: 4.130

2.  Nop53p is required for late 60S ribosome subunit maturation and nuclear export in yeast.

Authors:  Emma Thomson; David Tollervey
Journal:  RNA       Date:  2005-08       Impact factor: 4.942

Review 3.  Molecular pathogenesis of astrocytic tumours.

Authors:  Koichi Ichimura; Hiroko Ohgaki; Paul Kleihues; V Peter Collins
Journal:  J Neurooncol       Date:  2004-11       Impact factor: 4.130

4.  Low-level microsatellite instability phenotype in sporadic glioblastoma multiforme.

Authors:  R Martinez; H K Schackert; H Appelt; J Plaschke; G Baretton; G Schackert
Journal:  J Cancer Res Clin Oncol       Date:  2004-10-16       Impact factor: 4.553

Review 5.  Molecular pathogenesis of oligodendroglial tumors.

Authors:  Judith W M Jeuken; Andreas von Deimling; Pieter Wesseling
Journal:  J Neurooncol       Date:  2004-11       Impact factor: 4.130

Review 6.  Pathology and molecular genetics of oligodendroglial tumors.

Authors:  Christian Hartmann; Wolf Mueller; Andreas von Deimling
Journal:  J Mol Med (Berl)       Date:  2004-10       Impact factor: 4.599

7.  Comparative genomic hybridization analysis of astrocytomas: prognostic and diagnostic implications.

Authors:  Rodney N Wiltshire; James E Herndon; Annie Lloyd; Henry S Friedman; Darell D Bigner; Sandra H Bigner; Roger E McLendon
Journal:  J Mol Diagn       Date:  2004-08       Impact factor: 5.568

Review 8.  Oligodendrogliomas: an update on basic and clinical research.

Authors:  Marc Sanson; Lucinda Aguirre-Cruz; Stéphanie Cartalat-Carel; Khe Hoang-Xuan
Journal:  Curr Neurol Neurosci Rep       Date:  2003-05       Impact factor: 5.081

9.  Cytogenetic analyses in 81 patients with brain gliomas: correlation with clinical outcome and morphological data.

Authors:  Filip Kramar; Zuzana Zemanova; Kyra Michalova; Libuse Babicka; Sarka Ransdorfova; Petr Hrabal; Petr Kozler
Journal:  J Neurooncol       Date:  2007-06-14       Impact factor: 4.130

10.  1p/19q testing has no significance in the workup of glioblastomas.

Authors:  K H Clark; J L Villano; M N Nikiforova; R L Hamilton; C Horbinski
Journal:  Neuropathol Appl Neurobiol       Date:  2013-10       Impact factor: 8.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.